Latest news
Krystal Biotech Inc Unsponsored BDR Revenue Breakdown – BMFBOVESPA:K1YS34 - TradingViewTradingView · Tue, 04 Aug 2026 03:39:04 GMTKRYS: 2Q 2026 delivered record revenue and EPS, driven by global VYJUVEK growth and pipeline progress - TradingViewTradingView · Mon, 03 Aug 2026 19:36:15 GMTKRYS: Q2 2026 delivered 24% revenue growth, strong VYJUVEK demand, and advancing clinical milestones - TradingViewTradingView · Mon, 03 Aug 2026 14:46:23 GMTKrystal Biotech Q2 Earnings Call Highlights - TradingViewTradingView · Mon, 03 Aug 2026 14:04:36 GMTKrystal Biotech Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Mon, 03 Aug 2026 13:31:45 GMTKrystal Biotech Q2 revenue rises on VYJUVEK strength - TradingViewTradingView · Mon, 03 Aug 2026 11:12:32 GMTKrystal Biotech 2Q 2026: Revenue $119.22M, EPS $1.79— 10-Q Summary - TradingViewTradingView · Mon, 03 Aug 2026 11:11:01 GMTKRYS: Q2 2026 delivered strong revenue growth, high margins, and advancing global expansion - TradingViewTradingView · Mon, 03 Aug 2026 11:02:39 GMT